ProCE Banner Activity

Practical Strategies for BTK Inhibitors in B-Cell Malignancies

Slideset Download

Download this slideset from a live webinar to review key pharmacist and nursing considerations in the use of BTK inhibitors for CLL and MCL.

Released: December 16, 2022

Expiration: December 15, 2023

No longer available for credit.

Share

Faculty

Karen M. Fancher

Karen M. Fancher, PharmD, BCOP

Associate Professor of Pharmacy Practice
Duquesne University School of Pharmacy
Clinical Pharmacy Specialist, Oncology
University of Pittsburgh Medical Center Passavant
Pittsburgh, Pennsylvania

Anthony Perissinotti

Anthony Perissinotti, PharmD, BCOP

Hematology Clinical Pharmacist Specialist
Clinical Team Leader
, Hematology/Oncology
Adjunct Clinical Assistant Professor
University of Michigan, Michigan Medicine
Roger Cancer Center
Ann Arbor, Michigan

Supporters

Supported by an educational grant from

Pharmacyclics LLC, an AbbVie Company

Partners

National Association of Specialty Pharmacy

ProCE Banner

Faculty Disclosure

Karen M. Fancher, PharmD, BCOP: consultant/advisor/speaker: AstraZeneca, BTG Specialty Pharmaceuticals, G1 Therapeutics, LP Pharmaceuticals, Merck.

Anthony Perissinotti, PharmD, BCOP: consultant: AbbVie, BeiGene, Janssen, Pfizer, Rigel, Sanofi-Aventis, Servier.

Additional Information

Program Medium

This program has been made available online.